GHK cu UK: what to check before ordering GHK-cu for research
A buyer's check for ghk cu uk searches: the four public facts that make a GHK-cu listing checkable, what the published Certificate reports for batch 26155, and where the AKH BioLabs product page and archive show each one.
Where to buy GHK-cu for research is settled by four checkable facts: a Certificate from a named laboratory outside the seller for that exact product, the identity and purity that report states, delivery to the destination country, and a public review record read with its volume.
This article is written for laboratory buyers comparing GHK-cu suppliers, and it covers what each check settles, what the published batch record reports, and where price sits in the decision. GHK-cu 100mg is the AKH BioLabs presentation, supplied as lyophilised powder with its Certificate published on the product page.
Key takeaways
- A checkable listing publishes a Certificate for that exact product and names the laboratory, the batch and the test date on it.
- The GHK-cu Certificate covers batch 26155, tested 03 Aug 2026 by the Brown Institute of Biomolecular Research at a stated purity of 99.64%.
- A purity figure is a chromatographic ratio for one batch, not the share of vial mass that is the peptide.
- The GHK-Cu literature is dominated by cell and animal work, and controlled human evidence is thin and mixed.
Where to buy ghk cu: the four checks that settle it
The same four checks answer where to buy ghk cu for laboratory work, and none of them depends on a seller's own description of quality.
- 01
A Certificate for that exact product
The COA archive describes each row as one Certificate: one batch, tested once, by a named laboratory outside AKH on a report ordered by the manufacturer. A certificate naming a different compound, or issued for a different product, is not tied to the vial on sale.
- 02
The identity and purity it reports
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, with formula C14H24CuN6O4 and PubChem CID 378611. A report should name the compound and give a purity result for the batch rather than a general claim about a product line.
- 03
Delivery to the destination country
The AKH BioLabs listing states worldwide delivery in a 9 to 14 day window.
- 04
A public review record, read with its volume
The GHK-cu page shows a Trustpilot rating of 4.7 from 28 reviews. A rating means little without the count, so the two figures belong together, and neither of them describes the material in the vial.
What the GHK-cu Certificate reports
The published record for GHK-cu is batch 26155, tested 03 Aug 2026 by the Brown Institute of Biomolecular Research, with a purity of 99.64% and a 100mg fill. The same batch appears as one row in the archive, which lists 45 published reports across the catalogue.
The 100mg is the stated fill and the 99.64% is that batch's chromatographic purity result. The research record notes that lyophilised peptide is normally supplied as an acetate or trifluoroacetate salt and carries residual water, so the mass of powder in a vial is not the same quantity as the peptide mass. The research record states that chromatographic purity on a certificate of analysis does not resolve that difference either.
| Field | What it states | What it does not state |
|---|---|---|
| Batch 26155 | Which material the measurements apply to | That other batches of the same product were tested in the same way |
| Test date, 03 Aug 2026 | When the analysis was run | How the material was stored between testing and delivery |
| Laboratory, Brown Institute of Biomolecular Research | Who produced the measurement | Any approval of the product for a particular use |
The ghk cu price, the stated form and the delivery terms
The ghk cu price is displayed on the product page rather than in this article, in the visitor's currency beside the 100mg size. Price is a commercial fact that moves with presentation, promotions and delivery terms; it is not a measurement of the material and says nothing about a batch.
What can be read from the same listing is the form supplied and the terms attached: 100mg of lyophilised powder for laboratory research, formula C14H24CuN6O4, worldwide delivery in 9 to 14 days, and a stated reshipment or full-refund policy. The page also states that the material is not for human or veterinary use, which is an intended-use statement rather than a quality claim.
A comparison drawn on price alone leaves the checkable fields unread. The Certificate, the laboratory named on it, the batch number and the delivery terms are what distinguish one listing from another.
What the published GHK-Cu record covers
The GHK-Cu research record lists 15 published studies, 10 of them since 2023, with the newest dated 2026. Cell-culture work reports increased fibroblast collagen and glycosaminoglycan synthesis at picomolar to nanomolar concentrations, and gene-expression studies describe broad modulation of extracellular-matrix, antioxidant and inflammatory programmes.
Human data are limited and mixed. The record states that a small number of controlled trials of GHK-Cu in a skin formulation produced mixed results, including two randomised trials that found no advantage over comparator or placebo. A 2026 review of therapeutic peptides in orthopaedics lists GHK-Cu among wound-healing peptides and states that preclinical studies are promising while clinical trials are currently lacking.
That literature belongs to the evidence record rather than to a buying decision, and the record sets out what it does not establish. A Certificate describes a batch of material; it neither adds to nor contradicts the clinical position in either direction.
Before ordering: matching the vial to the published record
The last check happens after delivery. The batch number on the container should match the batch number on the published report; if it does not, the measurements describe different material, whatever the purity figure says.
The AKH BioLabs presentation is 100mg of lyophilised powder with formula C14H24CuN6O4 and a stated purity of 99.64% for batch 26155, and its Certificate is published on the GHK-cu product page. The archive holds every published Certificate in one table, so the batch printed on a delivered vial can be matched against the row for that product.
Anything the listing leaves unstated is a question for the seller before ordering: the storage conditions for the powder and the terms behind the reshipment policy.
Common questions.
- What makes a ghk cu uk listing checkable before ordering?
Four public fields: a Certificate published for that exact product, the laboratory, batch number and test date it carries, delivery to the destination country, and a review record read with its count. On the AKH BioLabs site the Certificate sits on the product page and the same row appears in the COA archive, so the two can be compared with each other before an order is placed.
- Where is the ghk cu price shown, and what does it cover?
On the product page, in the visitor's currency, beside the stated 100mg size. It covers the presentation offered and the seller's commercial terms, which include the delivery window and the stated reshipment or full-refund policy. It is a commercial figure rather than a batch measurement, and it does not describe the material in the vial.
- Is GHK-Cu the same molecule as GHK?
No. GHK is the tripeptide glycyl-L-histidyl-lysine, and GHK-Cu is its copper(II) complex. The research record gives the formula C14H24CuN6O4, a molecular weight of 403.92 g/mol and PubChem CID 378611, and lists Cu-GHK as an alternative writing. A listing that names only GHK describes the peptide without the copper ion.
- How much controlled human evidence exists for GHK-Cu?
Thin and mixed. The research record lists 15 published studies, 6 of them in humans, and a 2026 systematic review located only two randomised controlled trials of GHK-Cu as a standalone aesthetic intervention. The two largest randomised trials found no significant difference from comparator or placebo on the objective endpoints measured, one of them in 13 completers, and most positive human reports come from uncontrolled studies of multi-ingredient formulations.